Jing Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jing Zhang has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Le Zhang
Department of Endocrinology, Shengjing Hospital of China Medical University, Shenyang, China
2 shared publications - Bing Ma
The First Hospital of China Medical University
1 shared publication Cheng Cheng
Shengjing Hospital of China Medical University
1 shared publication- Cong Shang
Shengjing Hospital of China Medical University
1 shared publication - Hao Sun
Department of Clinical Epidemiology and Evidence-based Medicine, The First Hospital of China Medical University, Shenyang, China
1 shared publication Jianyi Li
Department of Breast Surgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning, 110004, China
1 shared publication
Latest Publications
- 17 October 2026
- Published by Springer Nature in Drugs
- p. 1-28
Glucose-Lowering Therapies in Type 2 Diabetes-Associated Sarcopenia: Mechanisms, Clinical Evidence and a Muscle-Centred Framework
- 17 October 2026
- Published by Springer Nature in Drugs
- p. 1-28
Glucose-Lowering Therapies in Type 2 Diabetes-Associated Sarcopenia: Mechanisms, Clinical Evidence and a Muscle-Centred Framework
- Open Access
- 21 July 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (14) , e047359
Associations of Physical Activity With Mortality Across Cardiovascular–Kidney–Metabolic Syndrome Stages: Evidence From NHANES 1999 to 2018
Background: Cardiovascular–kidney–metabolic (CKM) syndrome integrates cardiovascular, renal, and metabolic dysfunction and is associated with high mortality. Stage‐stratified evidence linking physical activity (PA) to mortality remains limited. Methods: We analyzed 19 930 adults with CKM stages 0 to 4 from the NHANES (National Health and Nutrition Examination Survey, 1999–2018), with mortality follow‐up through 2019. PA was assessed by duration (minute/week) and volume (metabolic equivalent of task‐min/week) across recreational, transport, and occupational domains. Survey‐weighted Cox models with restricted cubic splines characterized dose–response associations, defined restricted cubic spline‐derived reference ranges, and tested interactions. Results: During follow‐up, 2759 deaths occurred (997 CKM related). Mortality increased sharply with CKM stage (all cause: 2.7% in CKM 0–1, 7.0% in CKM 2, and 33.5%–39.2% in CKM 3–4; CKM‐related: <2% in CKM 0–2 and 14.2%–15.5% in CKM 3–4). Higher PA was associated with lower mortality across stages, with the largest absolute differences in CKM 3–4. Associations were nonlinear and L‐shaped. In CKM 3–4, total PA near the reference range (≈500 min/week or ≈2000 metabolic equivalent of task‐min/week) was associated with lower all‐cause mortality (hazard ratio [HR], 0.745–0.700) and CKM‐related mortality (HR, 0.739–0.690), whereas recreational PA (≈250 min/week or ≈1000 metabolic equivalent of task‐min/week) showed the strongest inverse associations (all‐cause HR, 0.740–0.702; CKM‐related HR, 0.568–0.550). Occupational PA displayed a U‐/J‐shaped pattern. Interactions were strongest for renal dysfunction, particularly proteinuria. Conclusions: Modest, attainable PA—especially recreational activity—was associated with lower all‐cause and CKM‐related mortality, with the greatest differences in CKM stages 3 to 4.
- 21 July 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (14) , e047359
Open AccessAssociations of Physical Activity With Mortality Across Cardiovascular–Kidney–Metabolic Syndrome Stages: Evidence From NHANES 1999 to 2018
Background: Cardiovascular–kidney–metabolic (CKM) syndrome integrates cardiovascular, renal, and metabolic dysfunction and is associated with high mortality. Stage‐stratified evidence linking physical activity (PA) to mortality remains limited. Methods: We analyzed 19 930 adults with CKM stages 0 to 4 from the NHANES (National Health and Nutrition Examination Survey, 1999–2018), with mortality follow‐up through 2019. PA was assessed by duration (minute/week) and volume (metabolic equivalent of task‐min/week) across recreational, transport, and occupational domains. Survey‐weighted Cox models with restricted cubic splines characterized dose–response associations, defined restricted cubic spline‐derived reference ranges, and tested interactions. Results: During follow‐up, 2759 deaths occurred (997 CKM related). Mortality increased sharply with CKM stage (all cause: 2.7% in CKM 0–1, 7.0% in CKM 2, and 33.5%–39.2% in CKM 3–4; CKM‐related: <2% in CKM 0–2 and 14.2%–15.5% in CKM 3–4). Higher PA was associated with lower mortality across stages, with the largest absolute differences in CKM 3–4. Associations were nonlinear and L‐shaped. In CKM 3–4, total PA near the reference range (≈500 min/week or ≈2000 metabolic equivalent of task‐min/week) was associated with lower all‐cause mortality (hazard ratio [HR], 0.745–0.700) and CKM‐related mortality (HR, 0.739–0.690), whereas recreational PA (≈250 min/week or ≈1000 metabolic equivalent of task‐min/week) showed the strongest inverse associations (all‐cause HR, 0.740–0.702; CKM‐related HR, 0.568–0.550). Occupational PA displayed a U‐/J‐shaped pattern. Interactions were strongest for renal dysfunction, particularly proteinuria. Conclusions: Modest, attainable PA—especially recreational activity—was associated with lower all‐cause and CKM‐related mortality, with the greatest differences in CKM stages 3 to 4.